These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24503204)

  • 21. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW; Plummer P; Backus D; Hebert JR; Neal WN; Ng A; Lowman J; Bethoux F; Schmidt H; McBurney R; McCully KK; Cutter G
    Mult Scler Relat Disord; 2024 Aug; 88():105715. PubMed ID: 38889558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.
    Dalgas U; Langeskov-Christensen M; Skjerbæk A; Jensen E; Baert I; Romberg A; Santoyo Medina C; Gebara B; Maertens de Noordhout B; Knuts K; Béthoux F; Rasova K; Severijns D; Bibby BM; Kalron A; Norman B; Van Geel F; Wens I; Feys P
    J Neurol Sci; 2018 Apr; 387():179-186. PubMed ID: 29571860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the T25FW in minimally disabled people with multiple sclerosis.
    Helmlinger B; Pinter D; Hechenberger S; Bachmaier G; Khalil M; Heschl B; Damulina A; Pichler A; Enzinger C
    J Neurol Sci; 2024 Jul; 462():123073. PubMed ID: 38852261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
    Learmonth YC; Dlugonski DD; Pilutti LA; Sandroff BM; Motl RW
    Mult Scler; 2013 Nov; 19(13):1784-91. PubMed ID: 23587605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Searching for the "Active Ingredients" in Physical Rehabilitation Programs Across Europe, Necessary to Improve Mobility in People With Multiple Sclerosis: A Multicenter Study.
    Kalron A; Feys P; Dalgas U; Smedal T; Freeman J; Romberg A; Conyers H; Elorriaga I; Gebara B; Merilainen J; Heric-Mansrud A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; O Eijnde B; Rasova K; Santoyo Medina C; Baert I
    Neurorehabil Neural Repair; 2019 Apr; 33(4):260-270. PubMed ID: 30880560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Changes in Gait and Balance Across the Disease Step Rating Scale in Multiple Sclerosis Statistically Significant and Clinically Meaningful?
    Williams KL; Low Choy NL; Brauer SG
    Arch Phys Med Rehabil; 2016 Sep; 97(9):1502-1508. PubMed ID: 27109334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.
    Bennett SE; Bromley LE; Fisher NM; Tomita MR; Niewczyk P
    Int J MS Care; 2017; 19(5):247-252. PubMed ID: 29070965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severity.
    Woelfle T; Pless S; Reyes Ó; Wiencierz A; Kappos L; Granziera C; Lorscheider J
    Mult Scler Relat Disord; 2023 Dec; 80():105104. PubMed ID: 37913676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.
    Goldman MD; Ward MD; Motl RW; Jones DE; Pula JH; Cadavid D
    Mult Scler; 2017 Sep; 23(10):1405-1414. PubMed ID: 27903937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review.
    Soler B; Ramari C; Valet M; Dalgas U; Feys P
    Expert Rev Neurother; 2020 Aug; 20(8):875-886. PubMed ID: 32729742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.
    Motl R; Neal W; Backus D; Hebert J; McCully K; Bethoux F; Plummer P; Ng A; Lowman J; Schmidt H; McBurney R; Cutter G
    BMC Neurol; 2024 Oct; 24(1):383. PubMed ID: 39390466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responsiveness of postural performance measures following balance rehabilitation in multiple sclerosis patients.
    Negahban H; Monjezi S; Mehravar M; Mostafaee N; Shoeibi A
    J Bodyw Mov Ther; 2018 Apr; 22(2):502-510. PubMed ID: 29861258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting long walking capacity from the timed 25-foot walk test in persons with multiple sclerosis - a potential simple aid to assist ambulation scoring?
    Ramari C; Feys P; Gaemelke T; Hvid LG; Baert I; Kalron A; Dalgas U;
    Mult Scler Relat Disord; 2021 Feb; 48():102706. PubMed ID: 33461129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gait pattern changes after six-minute walk test in persons with multiple sclerosis.
    Escudero-Uribe S; Hochsprung A; Izquierdo-Ayuso G
    Physiother Res Int; 2019 Jan; 24(1):e1741. PubMed ID: 30192036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
    Motl RW; Cohen JA; Benedict R; Phillips G; LaRocca N; Hudson LD; Rudick R;
    Mult Scler; 2017 Apr; 23(5):704-710. PubMed ID: 28206828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
    Engelhard MM; Schmidt KM; Engel CE; Brenton JN; Patek SD; Goldman MD
    Qual Life Res; 2016 Dec; 25(12):3221-3230. PubMed ID: 27342237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.